Susquehanna International Group’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47K Buy
38,827
+18
+0% +$23 ﹤0.01% 12651
2025
Q4
$48.5K Buy
38,809
+1
+0% +$1 ﹤0.01% 11760
2025
Q3
$50.1K Hold
38,808
﹤0.01% 11860
2025
Q2
$75.7K Sell
38,808
-21,141
-35% -$47K ﹤0.01% 11941
2025
Q1
$152K Buy
59,949
+16,107
+37% +$38.9K ﹤0.01% 11221
2024
Q4
$95.6K Sell
43,842
-26,754
-38% -$62.7K ﹤0.01% 11375
2024
Q3
$220K Buy
70,596
+26,039
+58% +$74.9K ﹤0.01% 10270
2024
Q2
$132K Buy
+44,557
New +$223K ﹤0.01% 10819
2024
Q1
Sell
-4,362
Closed -$43.5K 12164
2023
Q4
$43.5K Buy
+4,362
New +$35.4K ﹤0.01% 11766
2023
Q2
Sell
-2,913
Closed -$89.8K 12058
2023
Q1
$85.6K Sell
2,913
-4,609
-61% -$153K ﹤0.01% 11398
2022
Q4
$236K Sell
7,522
-1,628
-18% -$46.3K ﹤0.01% 9714
2022
Q3
$266K Buy
9,150
+1,894
+26% +$49K ﹤0.01% 10099
2022
Q2
$161K Buy
7,256
+2,434
+50% +$58.3K ﹤0.01% 10934
2022
Q1
$150K Buy
4,822
+436
+10% +$12.9K ﹤0.01% 11561
2021
Q4
$128K Buy
4,386
+1,466
+50% +$53.8K ﹤0.01% 11962
2021
Q3
$138K Buy
+2,920
New +$143K ﹤0.01% 11850
2019
Q4
Sell
-1,021
Closed -$51K 9707
2019
Q3
$51K Buy
+1,021
New +$73.3K ﹤0.01% 9769

Other funds holding BCDA

Susquehanna International Group's BCDA Position: Q1 2026 in Review

Susquehanna International Group increased its BioCardia (BCDA) stake by 0.05% in Q1 2026, buying an estimated $23 and bringing the position to 38,827 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #12651.

Susquehanna International Group first reported a position in BCDA in Q3 2019 and has held it in 17 quarters since. The position peaked at $266K in Q3 2022. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Susquehanna International Group held 38,827 shares of BioCardia worth $47K as of Q1 2026.
  • Susquehanna International Group bought 18 BioCardia shares in Q1 2026, an estimated $23.
  • BioCardia made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12651 holding.
  • Susquehanna International Group first reported a position in BioCardia in Q3 2019 and has held it in 17 quarters since.
  • Susquehanna International Group's BioCardia position peaked at $266K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.